Pancreatic cancer is likely to become the second most frequent cause of cancer-associated
mortality within the next decade. Surgical resection with adjuvant systemic chemotherapy …

Surgery is the only potential hope of cure for patients with pancreatic cancer. Advantageous
tumour characteristics and complete tumour resection are the factors most relevant for a …

Background Many studies have shown lower mortality and higher survival rates after
pancreatic surgery with high-volume providers, suggesting that centralization of pancreatic …

Importance To effectively guide interventions aimed at reducing mortality in low-volume
hospitals, the underlying mechanisms of the volume-outcome relationship must be further …

Background High morbidity and mortality rates after pancreaticoduodenectomy (PD) have
led to concentration of this surgery in high-volume centres, with improved outcomes. The …

OBJECTIVE The purpose of this study was to systematically review the research on volume
and outcome relationships in critical care. METHODS From January 1, 2001, to April 30 …

The distinct biology of pancreatic cancer with aggressive and early invasive tumor cells, a
tumor promoting microenvironment, late diagnosis, and high therapy resistance poses major …

Background Early death after cancer surgery is higher in low-income and middle-income
countries (LMICs) compared with in high-income countries, yet the impact of facility …

Background Failure to rescue (FTR) is a quality-of-care indicator in pancreatic surgery, but
may also identify patients who may not tolerate major postoperative complications despite …

Background: For more than a decade, health policy groups have recommended
concentrating care for certain high-risk oncologic procedures into high-volume centers. The …